Pharmaceutical compositions of a particularly effective sparingly soluble glycogen phosphorylase inhibitor are disclosed, as well as methods of making such compositions and dosage forms from such compositions.

 
Web www.patentalert.com

> Nucleolin-mediated cancer diagnostics and therapy

~ 00357